EastPharma reported sales results for the nine months of 2015. For the period, the company reported revenue of USD 158.3 million, up 1.1% from USD 156.6 million for the same period in 2014. Sales increase in US Dollar terms was mainly due to increased volumes in Human Pharma products business.
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |